Diabetes and risk of cancer incidence: results from a population-based cohort study in northern Italy

[1]  D. Serraino,et al.  Cancer among patients with type 2 diabetes mellitus: A population-based cohort study in northeastern Italy. , 2016, Cancer epidemiology.

[2]  S. Wild,et al.  Cancer incidence in persons with type 1 diabetes: a five-country study of 9,000 cancers in type 1 diabetic individuals , 2016, Diabetologia.

[3]  T. Byers Excess Mortality among Persons with Type 2 Diabetes. , 2016, The New England journal of medicine.

[4]  Bendix Carstensen,et al.  The Epidemiology of Diabetes and Cancer , 2014, Current Diabetes Reports.

[5]  J. Shaw,et al.  Global estimates of diabetes prevalence for 2013 and projections for 2035. , 2014, Diabetes Research and Clinical Practice.

[6]  P. Giorgi Rossi,et al.  Building a population-based diabetes register: an Italian experience. , 2014, Diabetes research and clinical practice.

[7]  L. Tjosvold,et al.  Insulin use and cancer risk in patients with type 2 diabetes: a systematic review and meta-analysis of observational studies. , 2012, Diabetes & metabolism.

[8]  B. Carstensen,et al.  Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence , 2012, Diabetologia.

[9]  S. Friis,et al.  Cancer occurrence in Danish diabetic patients: duration and insulin effects , 2012, Diabetologia.

[10]  E. Pagkalos Combinations of insulin and oral hypoglycemic agents in diabetes mellitus type 2. , 2011, Diabetes research and clinical practice.

[11]  S. Larsson,et al.  Diabetes mellitus and incidence of kidney cancer: a meta-analysis of cohort studies , 2011, Diabetologia.

[12]  Massimiliano Cazzaniga,et al.  Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis , 2010, Cancer Prevention Research.

[13]  M. Pollak,et al.  Insulin, glucose and the increased risk of cancer in patients with type 2 diabetes , 2010, Diabetologia.

[14]  Edward Giovannucci,et al.  Diabetes and Cancer , 2010, Diabetes Care.

[15]  D. Balzi,et al.  Doses of Insulin and Its Analogues and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients , 2010, Diabetes Care.

[16]  E. Gale,et al.  The influence of glucose-lowering therapies on cancer risk in type 2 diabetes , 2009, Diabetologia.

[17]  L. Hemkens,et al.  Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study , 2009, Diabetologia.

[18]  M. Zwahlen,et al.  Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies , 2008, The Lancet.

[19]  Alicja Wolk,et al.  Diabetes mellitus and risk of breast cancer: A meta‐analysis , 2007, International journal of cancer.

[20]  C. Mantzoros,et al.  Diabetes mellitus and risk of endometrial cancer: a meta-analysis , 2007, Diabetologia.

[21]  E. Giovannucci,et al.  A Meta-analysis of Diabetes Mellitus and the Risk of Prostate Cancer , 2006, Cancer Epidemiology Biomarkers & Prevention.

[22]  S. Larsson,et al.  Diabetes mellitus and risk of bladder cancer: a meta-analysis , 2006, Diabetologia.

[23]  H. El‐Serag,et al.  The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[24]  S. Larsson,et al.  Diabetes mellitus and risk of colorectal cancer: a meta-analysis. , 2005, Journal of the National Cancer Institute.

[25]  M. Woodward,et al.  Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies , 2005, British Journal of Cancer.

[26]  J. Lewis,et al.  Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. , 2004, Gastroenterology.